Dr. Danielle Sterrenberg, MD
Claim this profileIngalls Memorial Hospital
Studies Breast Cancer
Studies Breast cancer
9 reported clinical trials
18 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage IV
Stage III
2Breast Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Danielle Sterrenberg, MD is currently running
Long-term Niraparib
for Cancer
This trial provides continued access to niraparib for patients already receiving it in certain studies and aims to understand its ongoing safety. Niraparib helps stop cancer cells from repairing their DNA, which can kill the cancer. Niraparib is approved for use in ovarian cancer patients who respond to specific treatments.
Recruiting1 award Phase 23 criteria
GLSI-100
for HER2 Positive Breast Cancer
This is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects who are at high risk for disease recurrence and have completed both neoadjuvant and postoperative adjuvant standard of care therapy. Treatment consists of 6 intradermal injections, Primary Immunization Series (PIS), over the first 6 months of treatment and 5 booster intradermal injections spaced 6 months apart. A third open-label arm will explore GLSI-100 immunotherapy in non-HLA-A\*02 positive and HER2/neu positive subjects.
Recruiting1 award Phase 36 criteria
More about Danielle Sterrenberg, MD
Clinical Trial Related7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Danielle Sterrenberg, MD has experience with
- Placebo
- Pembrolizumab
- GLSI-100
- Surgery
- Active Monitoring
- Ladiratuzumab Vedotin
Breakdown of trials Danielle Sterrenberg, MD has run
Breast Cancer
Ductal Carcinoma In Situ
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Danielle Sterrenberg, MD specialize in?
Danielle Sterrenberg, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Danielle Sterrenberg, MD currently recruiting for clinical trials?
Yes, Danielle Sterrenberg, MD is currently recruiting for 2 clinical trials in Harvey Illinois. If you're interested in participating, you should apply.
Are there any treatments that Danielle Sterrenberg, MD has studied deeply?
Yes, Danielle Sterrenberg, MD has studied treatments such as Placebo, Pembrolizumab, GLSI-100.
What is the best way to schedule an appointment with Danielle Sterrenberg, MD?
Apply for one of the trials that Danielle Sterrenberg, MD is conducting.
What is the office address of Danielle Sterrenberg, MD?
The office of Danielle Sterrenberg, MD is located at: Ingalls Memorial Hospital, Harvey, Illinois 60426 United States. This is the address for their practice at the Ingalls Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.